HOIL-1L, 15, 744; SHARPIN, 19, 903) . Asterisk indicates an artifact of SDS-PAGE.
(B) Molecular weight estimation of the LUBAC ternary complex core, based on elution volume in analytical size exclusion column chromatography (A). Partition coefficients (K av ) of the trimeric LUBAC core and standard proteins were calculated from their elution volumes. The calibration curve was generated by plotting K av of each standard protein against a logarithm of its molecular weight. The molecular weight of the trimeric LUBAC core was estimated as 51.3 kDa, indicating that the three subunits are assembled in a 1:1:1 stoichiometry (theoretical molecular weight: 53,619).
(C) MS spectra of the protein fraction in (A). The three components co-existed in a single fraction.
(D) Comparison of UBL-binding mode between UBA1 and UBA2 in the ternary complex core. The α1 helix in UBA1 binds the surface of the conserved hydrophobic patch on the β-sheet of the mSHARPIN UBL, whereas α7 helix of UBA2 contacts with the opposite surface of the β-sheet of the mHOIL-1L UBL.
(E) UBA-UBL binding modes observed in the crystal structures of the human HOIP/SHARPIN (left panel, PDB:5X0W) and HOIP/HOIL-1L (right panel, PDB:4DBG) binary complexes. The UBAs are colored as in Figure 3E and 3F, whereas the UBLs are in white.
(F) Interface between mHOIP UBA1 and mSHARPIN UBL. Each subunit is colored as in Figure 3 . The interface is mainly formed between helices α1-α2 of mHOIP UBA1 and strands β4-β6 of mSHARPIN UBL.
mHOIP and mSHARPIN residues involved in the interaction are shown in stick models. Hydrogen bonds are indicated by red dotted lines. (E) The indicated expression plasmids and 5× NF-κB luciferase reporter were transfected into HEK293T cells.
NF-κB activity was measured by luciferase assays (mean ± s.e.m., n = 3).
(F) Conserved residues in HOIP UBA1 of various species. This study N/A pcDNA3.1 Myc-mSHARPIN ∆ aa This study N/A pcDNA3. were generated from the amplified ORFs of human and mouse HOIP. The following proteins were generated from the amplified ORF of mouse HOIL-1L: before NZF (aa 1-189), UBL (aa 1-140), Δ aa 1-36 (aa 37-509), and UBL Δ aa 1−36 (aa 37-161). The following proteins were generated from the amplified ORF of mouse SHARPIN:
Δ aa 163-197 (Δaa 163-197) , UBL (aa 163-301 or 163-340), and UBL Δ aa 163-197 (aa 198-318) . The following mutants of mHOIL-1L and mSHARPIN, in which the UBLs were exchanged, were generated from the amplified L15A/V19A), mSHARPIN (L176A, I180A, A192D, L176A/I180A), and hHOIL-1L (A18P) were generated by two-step PCR. cDNAs were ligated into the appropriate epitope-tag sequences, and then cloned into pcDNA3.1, pDNA3.1-MMTV, pMAL-c2x, pGEX-6p1, pMXs-IP, pMXs-neo, pMXs-puro-IRES-att (Bochkov and Palmenberg, 2006) , and pMXs-IRES-Bsr. pX330-U6-Chimeric_BB-CBh-hSpCas9 (Addgene plasmid #42230) (Cong et al., 2013) and pSpCas9(BB)-2A-Puro (PX459) (Addgene plasmid #48139) were obtained from Addgene.
Antibodies and reagents
Antibodies against the following proteins were purchased from Cell Signaling Technology and used at the To generate the anti-mouse HOIL-1L N-term antibody, strep-tagged mouse HOIL-1L N-terminus (aa 1-189) was expressed in Escherichia coli (Agilent Technologies), and then purified using Strep-Tactin Sepharose (IBA).
Purified protein was used to immunize rabbits, and IgG was purified from antisera using Protein A-Sepharose (GE Healthcare). SHARPIN peptide synthesis, reverse-phase high-performance liquid chromatography purification, and amino acid analysis were performed as described previously (Bernal et al., 2007) .
Cell lines
HEK293T cells, HEK293T HOIP KO cells, MEFs derived from WT, cpdm, HOIP Δlinear, HOIL-1L -/-, or HOIL-1L-null mice, and LUBAC TKO MEFs were grown in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal bovine serum (FBS) with 100 IU/ml penicillin and 100 µg/ml streptomycin, at 37°C under 7.5% CO 2 . HBL1 cells were grown at 37°C under 7.5% CO 2 in RPMI 1640 medium supplemented with 10% FBS, 100 IU/ml penicillin, and 100 µg/ml streptomycin.
Transfection and retroviral expression
Transfections were performed using Lipofectamine 2000. For retroviral expression, pMXs-IP, pMXs-puro-IRES-att, pMXs-neo, or pMXs-IRES-Bsr containing LUBAC components were transfected into Plat E packaging cells. The resultant viruses were used to infect LUBAC TKO MEFs, cpdm MEFs or HOIL-1L-null MEFs, and stably transduced cells were selected using puromycin, G-418, or blasticidin.
Cell lysis and immunoprecipitation
Cells were lysed with lysis buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 2 mM PMSF, and protease inhibitor cocktail (Sigma-Aldrich)], and the lysates were clarified by centrifugation at 15,000 rpm for 20 min at 4°C. For immunoprecipitation, lysates were incubated with the appropriate antibodies for 90 min on ice, and then immobilized on rmp-Protein A-Sepharose beads (GE Healthcare). The beads were washed five times with lysis buffer.
Immunoblotting and EMSA
Samples were separated by SDS-PAGE, and then transferred to PVDF membranes. After blocking in Tris-buffered saline (TBS) containing 0.1% Tween-20/5% (w/v) nonfat dry milk, the membrane was incubated with the appropriate primary antibodies, followed by the corresponding secondary antibodies. The membranes were visualized by enhanced chemiluminescence and analyzed on a LAS4000mini or LAS3000 instrument (GE Healthcare). EMSAs for NF-κB activity were performed using the Odyssey Infrared EMSA kit (LI-COR Biosciences) and IRDye 700 NF-κB consensus oligonucleotide (LI-COR Biosciences), and visualized on an
Odyssey 9120 Infrared Imaging System (LI-COR Biosciences). Cells were grown at 37°C until OD 660 reached 0.6; protein expression was induced by addition of IPTG to a final concentration of 0.5 mM, and culture was continued at 18°C overnight. Cells were harvested by centrifugation.
The cell pellet was resuspended in Buffer A (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 10% Glycerol, and 1 mM TCEP) and lysed by sonication. The lysate was clarified by centrifugation, and applied to a Ni-NTA agarose column (Qiagen). After extensive column washing, bound proteins were eluted in Buffer A containing 400 mM imidazole. Fractions containing the binary complex were pooled and co-purified with mSHARPIN LTM-UBL as described below. GST-mSHARPIN LTM-UBL was overexpressed in E. coli strain Rosetta2 (DE3) (Novagen) in LB medium. Cells were cultured and processed in the same manner as for purification of the HOIP-HOIL-1L
complex. The clarified lysate containing GST-mSHARPIN LTM-UBL was applied to a glutathione-Sepharose affinity column (GE Healthcare), and subsequently His-tagged mHOIP D-UBA-mHOIL-1L LTM-UBL complex was added to form the ternary complex. After incubation at 4°C for 30 min, unbound proteins were removed by extensive column washing. The ternary complex was eluted from the column by cleavage of the GST tag with 400 µM HRV3C protease. To cleave the His tag from mHOIP D-UBA, TEV protease (Promega) was added at a final concentration of 250 µM. The ternary complex was applied to a HiTrap Q HP anion exchange column (GE Healthcare) and eluted with a linear NaCl gradient from 50 to 600 mM. The complex was further purified by size-exclusion chromatography using HiLoad Superdex 16/60 200 pg (GE Healthcare) in a buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, and 1 mM TCEP. Peak fractions containing the stoichiometric ternary complex were combined, concentrated (typically to 7.0 mg/ml), and stored at 4°C until further use.
Analytical size-exclusion chromatography
Analytical size-exclusion chromatography for the LUBAC ternary complex core was performed at 4°C using Superdex 200 10/300 GL (GE Healthcare) in a buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, and 1 mM TCEP. Fractions were analyzed by SDS-PAGE, and visualized by CBB and mass spectroscopy. rapidly. Subsequently, the cells were resuspended in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM DTT (Nacalai Tesque), 200 µg/ml lysozyme chloride (Nacalai Tesque), 10 µg/ml DNase (Roche), 2 mM PMSF, and protease inhibitor cocktail (Roche) at 4°C for 30 min, and then lysed in the presence of 0.2% Triton X-100 at 4°C for 20 min. Insoluble material was removed by centrifugation at 14,000 rpm for 20 min at 4°C.
SPR analysis

GST-HOIP
GST-HOIP UBA was purified from the supernatant using glutathione-Sepharose beads (GE Healthcare), and MBP-HOIL-1L UBL and MBP-SHARPIN UBL were purified using Amylose Resin (NEB). Binding affinities between UBA and the UBLs were measured on a Biacore 3000 (GE Healthcare). GST-HOIP UBA was immobilized on a CM5 sensor chip with an anti-GST antibody using the GST capture kit (GE Healthcare) in 10 mM HEPES buffer (pH 7.4) containing 150 mM NaCl and 0.05% (v/v) surfactant P20 at 25°C. Binding between GST-HOIP UBA and MBP-UBLs was measured in 10 mM HEPES buffer (pH 7.4) containing 150 mM NaCl and 0.05% (v/v) surfactant P20 at 25°C. The K d of HOIL-1L UBL-HOIP UBA or SHARPIN UBL-HOIP UBA was calculated by steady-state affinity analysis. In Figures 2G and 2I , 4E-4G, and S2F, the binding affinities of HOIP UBA for HOIL-1L UBL alone (500 µg/ml), SHARPIN UBL alone (500 µg/ml), and the mixture of HOIL-1L and SHARPIN UBL (500 µg/ml each) were measured. In Figure 4C and 4D, to immobilize HOIL-1L
(aa 1-189)-strep, anti-mouse antibody was first immobilized on the sensor chip using the mouse antibody capture kit (GE Healthcare). StrepMAB-Immo (IBA Lifesciences) was then applied to capture HOIL-1L (aa 1-189)-strep. Binding between HOIL-1L (aa 1-189)-strep and MBP-SHARPIN UBLs was measured in 10 mM HEPES buffer (pH 7.4) containing 150 mM NaCl and 0.05% (v/v) surfactant P20 at 25°C.
Generation of cell lines
To generate HOIP-HOIL-1L-SHARPIN TKO MEFs, MEFs from mice with cpdm were electroporated using a NEPA21 electroporator (NEPAGENE) with pX330 plasmid containing a gRNA sequence against mHOIP or mHOIL-1L. After 4 days of culture, cells were seeded at low density. Colonies were picked, and the expression level of LUBAC was analyzed by immunoblotting as a primary screen. Next, genomic regions of HOIL-1L or HOIP were amplified by PCR using the following primers: mHOIL-1L typing_Fwd (5'-TTGCCAACAGGCCAATTTGATG-3') and typing_Rev (5'-TGCGGTGATGCACAATATCCTG-3'); mHOIP typing_Fwd (5'-AGCGCCCTGAGGTGGGATT-3') and typing_Rev (5'-GCGCTCCTCAGTATAGCCATACAACC-3'). PCR products were cloned into the TOPO cloning vector (Invitrogen), and mutations were identified by sequencing. To generate HEK293T HOIP KO cells, HEK293T cells were transfected using Lipofectamine 2000 (Invitrogen) with a pX459 plasmid containing a gRNA sequence against hHOIP. Starting on the following day, cells were selected with puromycin for 2 days.
Following selection, the cells were seeded at a low density, and isolated colonies were picked. To identify HOIP KO cells, the expression level of HOIP was analyzed by immunoblotting, and the HOIP locus was amplified by PCR using the following primers: hHOIP typing_Fwd (5'-TTCCGGGCAGGCGTTTTCCCTG-3') and typing_Rev (5'-CTCTGTGTAGCCATATAATCG-3') PCR products were analyzed by sequencing. Primary
MEFs from HOIL-1L-null or WT littermate mice were immortalized with SV-40 large T antigen. In Figure 5F , HOIL-1L null/null MEFs were transfected with pcDNA3.1 MMTV-FLAG mHOIL-1L or A18P using Lipofectamine 2000 (Invitrogen). The next day, cells were seeded at a low density and selected with G-418, and single colonies were picked.
Luciferase assay
HEK293T cells were transfected with pGL4.32 (Luc2p/NF-κB-RE/Hygro) and pGL4.74 (hRLuc/TK) (Promega) along with WT or mutant LUBAC components. At 21-24 h after transfection, cells were lysed, and luciferase activity was measured using the Dual-Luciferase reporter assay system (Promega) on a Lumat
Luminometer (Berthold).
